Computational Study of Anticancer Dasatinib for Drug Delivery Systems

Document Type : Review Paper


Dasatinib is a tyrosine kinase inhibitor (TKI) that is used to treat chronic myeloid leukemia
and in the management of ulcerative colitis (UC) and to provide appropriate results in treatment. Dasatinib is significantly higher and faster than full cytogenetic and large molecular responses as compared to imatinib. In the recent study, using the NMR data, thermochemical properties of the dasatinib structure and the attached form of this molecule have been explored and analyzed. In this paper, we will examine some computational studies on this subject using semi-empirical and Monte Carlo methods. The Hyperchem 8.0 and Gaussian 09 and Gauss View 05 were used to do these methods for simulating molecular mechanics (MM+) and semi empirical. Quantum mechanics was calculated using B3LYP methods and the theoretical method of 6-31G. As a result, our findings indicate that the presence of Dasatinib can express the results of this molecule as anticancer agents.